Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
HealthVerity has signed a multi-year Research Collaboration Agreement with the FDA to evaluate a range of different real-world datasets for their potential to inform the FDA's response to COVID-19.
read more
Friday, November 01, 2019
HealthTrust has awarded a 36-month group purchasing agreement effective November 1, 2019 for EcoVue ultrasound gel to York, Pennsylvania based HR Pharmaceuticals.
read more
HealthCore, Inc. will collaborate with PCORnet, the National Patient-Centered Clinical Research Network, on building a sustainable patient-centered outcomes research network to conduct real-world comparative effectiveness research as part of a ...
read more
Healthcare Triangle announced its formation as a new privately held U.S.-based company combining life sciences, healthcare delivery and business methodologies to accelerate cloud transformation, data lifecycle management and operational improvement ...
read more
Wednesday, August 22, 2018
Representatives from leading healthcare industry companies and associations, came together to explore the use of blockchain technology to support Drug Supply Chain Security Act (DSCSA) compliance.
read more
Monday, December 14, 2020
Health Decisions and OncoBay Clinical announced a partnership to deliver specialized clinical development services for pharmaceutical and biotechnology companies developing therapeutics, medical devices, and diagnostics in oncology.
read more
Friday, February 16, 2018
B·R·A·H·M·S GmbH announced its sFlt-1, PlGF plus, PAPP-A and Free ßhCG KRYPTOR assays have received Class III Medical Device System License from Health Canada as an aid in screening for the risk of fetal trisomy 21, 18 and 13.
read more
Wednesday, October 11, 2023
Eurofins CDMO Alphora announced that it received its Health Canada Cannabis Drug License issued within the Cannabis Act and Cannabis Regulations for its Oakville, Ontario operations in September 2023.
read more
Headlands Research announced its research centers have been selected to participate in numerous upcoming COVID-19 vaccine clinical trials.
read more
Wednesday, August 20, 2025
Headlands Research announced the opening of Headlands Research Twin Cities (HRTC), its 23rd fully owned site. Strategically situated in the Minneapolis–St. Paul metro area, the new center offers pharmaceutical sponsors and CROs rapid, single-contract...
read more
Headlands Research announced its acquisition of two large CNS-focused clinical research centers; JEM Research Institute and Toronto Memory Program.
read more
Friday, February 19, 2021
Headlands Research has acquired Artemis Institute for Clinical Research.
read more
HCL Technologies Limited announced the acquisition of C3i Solutions, a multi-channel customer engagement services for the life sciences and consumer packaged goods (CPG) industries, from Merck.
read more
HCATS and apceth Biopharma have expanded their relationship with bluebird bio with long-term development and manufacturing services agreements for clinical and commercial supply for multiple therapies.
read more
Hawkins has announced that it recently completed its acquisition of Stauber Performance Ingredients from ICV Partners II, L.P. and its other shareholders in a cash for stock transaction.
read more